-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Milestone Pharmaceuticals (NASDAQ:MIST) Receives “Buy” Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Milestone Pharmaceuticals (NASDAQ:MIST – Free Report) in a research note published on Friday,Benzinga reports. The firm currently has a $25.00 price target on the stock. Milestone Pharmaceuticals Stock Down 6.3 % Shares of Milestone Pharmaceuticals stock opened at $1.63 on Friday. The company has a market […]
HC Wainwright reaffirmed their buy rating on shares of Milestone Pharmaceuticals (NASDAQ:MIST – Free Report) in a research note published on Friday,Benzinga reports. The firm currently has a $25.00 price target on the stock. Milestone Pharmaceuticals Stock Down 6.3 % Shares of Milestone Pharmaceuticals stock opened at $1.63 on Friday. The company has a market […]
